QuantiFERON Change During Anti-tuberculosis Medication

Armed Forces Capital Hospital, Republic of Korea

Status: Completed

Conditions: Tuberculosis; Interferon-gamma Release Assay

Study type: Observational

Funder types: Other

Identifiers

NCT01038830

QFTchange

Details and patient eligibility

About

The aim of this study is to evaluate the change of QuantiFERON-TB gold in tube assay (QFT) during the treatment of active tuberculosis.

Full description

Patients with active pulmonary tuberculosis are enrolled and, QFTs are performed for each subjects before treatment and 1, 3, 6 months after treatment. Investigators check the level of interferon-gamma, and reversion and conversion of this test.

Enrollment: 50 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• All subjects with active tuberculosis

Exclusion criteria

• Subjects who cannot complete study
• Subjects who have taken anti-tuberculosis medication for more than a month before visit of our hospital